Why did MOLN.SW stock jump pre-market today?

MOLN.SW stock rose **6.16%** pre-market on stronger trading interest ahead of clinical readouts and sector momentum; volume was **27071.00** against an average **31138.00**, indicating concentrated buying.

What is Meyka AI's grade for MOLN.SW stock?

Meyka AI rates MOLN.SW with a score out of 100: **64.30 / 100 (B)**, suggestion **HOLD**. The grade includes benchmark, sector, metrics, growth and analyst inputs.

What are realistic price targets for MOLN.SW stock?

Our framework gives a conservative target **CHF 3.80** (up **4.97%**), bull target **CHF 4.60** (up **27.07%**), and bear **CHF 2.80** (down **-22.65%**) from current **CHF 3.62**.

When are the next key events for MOLN.SW stock?

Earnings and corporate updates are scheduled around **2026-03-12**; upcoming clinical readouts for late‑stage assets will be the primary catalysts for MOLN.SW stock movement.

CH Stocks

MOLN.SW Molecular Partners AG (SIX) up 6.16% pre-market 17 Feb 2026: catalysts may extend gains

ByDanny Kontos February 17, 2026February 17, 2026

Molecular Partners AG (MOLN.SW) jumps 6.16% pre-market to CHF 3.62 on 17 Feb 2026 after higher trade interest and positive sector momentum. The move makes MOLN.SW stock one of Switzerland’s top pre-market gainers on the SIX exchange, with volume 27071.00 versus an average of 31138.00. Investors watch upcoming clinical readouts and a March earnings window that could crystallise direction. Meyka AI provides this real-time analysis and the forecast context for traders and longer-term investors.